Cycling News on MSN
An altitude alibi: Does cycling's anti-doping system have a major loophole?
Cycling's recent nighttime anti-doping wake-up calls highlighted concerns that micro-dosing is fuelling an ever-accelerating ...
DCGI cleared Phase III trials of Zydus’ Desidustat for sickle cell disease. If proven safe and effective, the oral drug could offer an accessible new treatment option for millions of Indians.
ENDEAVORDuring the waning months of my stint as Communications Secretary to then President Benigno ‘Noynoy’ Aquino III, I had a talk with the Chairman ...
Tiny brain bleeds become more common as people grow older and are linked to memory problems, stroke, and dementia. For many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results